Ticker Sage

Company file · IEX

IDEX

Health and Science Technologies was IDEX's fastest-growing segment in FY2025, up 15.2%

Revenue rose 5.8% to $3.5B in FY2025, from $3.3B in FY2024. Net income fell 4.3% to $483M. Health and Science Technologies was the largest segment, at 43% of revenue.

Key facts

IDEX (NYSE: IEX) closed fiscal 2025 on Dec 31, 2025 with revenue of $3.5B, up 5.8% from a year before; net income came to $483M, down 4.3%. Its newest quarterly report covers the three months to Sep 30, 2026: revenue of $952M, up 8.3% on the same stretch of the prior year, and net income of $144M. Broken down by segment, Health and Science Technologies led with 43% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 19, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Oct 28, 2026).

Revenue$3.5BFY2025 · +5.8% vs FY2024
Net income$483MFY2025 · −4.3% vs FY2024
Operating cash flow$680MFY2025 · +1.8% vs FY2024
Cash & equivalents$602Mat Sep 30, 2026 · +3.8% vs FY2025 end
Total debt$1.8Bat Sep 30, 2026 · −3.8% vs FY2025 end
Diluted shares75MFY2025 avg · −0.8% vs FY2024
Revenue and net income, three fiscal yearsBy fiscal year, $bn
RevenueNet income
Revenue and net income by fiscal yearRevenue FY2023: $3.3B3.3Net income FY2023: $596M0.60FY2023Revenue FY2024: $3.3B3.3Net income FY2024: $505M0.51FY2024Revenue FY2025: $3.5B3.5Net income FY2025: $483M0.48FY2025Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-K FY2025, filed Feb 19, 2026

Quarterly revenue: fiscal 2026 vs a year earlierFiscal Q1–Q3, $bn (each quarter from that quarter's 10-Q)
FY2025FY2026
Quarterly revenue, fiscal 2026 vs 2025FY2025 Q1: $814M0.81FY2026 Q1: $887M0.89Q1FY2025 Q2: $865M0.87FY2026 Q2: $921M0.92Q2FY2025 Q3: $879M0.88FY2026 Q3: $952M0.95Q3Data: Ticker Sage, from SEC EDGAR · tickersage.com

Source: 10-Q filed Apr 29, 2026 · 10-Q filed Jul 29, 2026 · 10-Q filed Oct 28, 2026

How it makes money

FY2025 total by categoryHealth and Science Technologies: $1.5B (43%)Fluid and Metering Technologies: $1.2B (35%)Fire and Safety Diversified Products: $744M (22%)$3.5BFY2025 totalData: Ticker Sage, from SEC EDGARtickersage.com

By segment, FY2025

  • LineAmountSharevs FY2024
  • Health and Science Technologies$1.5B43%+15.2%
  • Fluid and Metering Technologies$1.2B35%−0.8%
  • Fire and Safety Diversified Products$744M22%+0.2%

Source: 10-K FY2025, XBRL breakdown

By segment in FY2025: Health and Science Technologies (43%), Fluid and Metering Technologies (35%) and Fire and Safety Diversified Products (22%), as shares of total revenue. Total revenue was $3.5B.

By segment: three-year mixShare of the total each fiscal year
Health and Science TechnologiesFluid and Metering TechnologiesFire and Safety Diversified Products

Source: 10-K FY2025

By region, FY2025

United States$1.8B51%+8.6%
Europe$846M24%+6.2%
Asia$563M16%−1.4%
Other Geographical Areas$165M5%+7.2%
North America, Excluding United States$130M4%−2.0%

Share is of the FY2025 total; the last column is the change from FY2024.

Learn more: Revenue vs. net income · Gross, operating and net margin

What changed last quarter

How the quarter compared with a year earlier

Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)

Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.

Q3 2026Q3 2025

Company

Revenue
$952M Q3 2026
$879M Q3 2025
8.3% increase
Net income
$144M Q3 2026
$128M Q3 2025
12.8% increase

Source: IDEX 10-Q for the quarter ended Sep 30, 2026, filed Oct 28, 2026

By segment

Health and Science Technologies
$432M Q3 2026
$380M Q3 2025
13.8% increase
Fluid and Metering Technologies
$328M Q3 2026
$317M Q3 2025
3.5% increase
Fire and Safety Diversified Products
$191M Q3 2026
$182M Q3 2025
5.3% increase

Source: IDEX 10-Q for the quarter ended Sep 30, 2026, filed Oct 28, 2026

  • Cash & equivalents $602M at Sep 30, 2026, vs $580M at FY2025 end.
  • Total debt $1.8B at Sep 30, 2026, vs $1.8B at FY2025 end.
  • Operating cash flow, first 9 months of fiscal 2026: $543M vs $471M a year earlier.

The bull case and the bear case

The bull case

The bear case

  • Net income fell 4.3% in FY2025 to $483M, from $505M. 10-K, FY2025
  • Fluid and Metering Technologies revenue fell 0.8% in FY2025 to $1.2B. 10-K, FY2025
  • North America, Excluding United States revenue fell 2.0% in FY2025 to $130M. 10-K, FY2025

What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.

What the company does

IDEX is in the industrial machinery & supplies & components industry, part of the industrials sector. The SEC files it under Pumps & Pumping Equipment.

IDEX reports 3 segments: Health and Science Technologies, Fluid and Metering Technologies and Fire and Safety Diversified Products.

Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.

Source: 10-K, Item 1 Business

Risks common in this industry

These are general risks for companies in the industrial machinery & supplies & components industry. They are not a summary of IDEX’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.

  1. Economic cyclesDemand for equipment and services rises and falls with business investment.
  2. Costs and supplyMaterial, labor and supplier problems can raise costs or delay delivery.
  3. Trade and tariffsTariffs and trade policy affect costs and sales.
  4. Contracts and backlogLarge projects and government contracts can be delayed, cut or repriced.
  5. Regulation and liabilitySafety, environmental and product-liability rules can raise costs.

Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)

Three years of key numbers

Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.

US$FY2023FY2024FY2025
Revenue$3.3B$3.3B$3.5B
Net income$596M$505M$483M
Operating cash flow$717M$668M$680M
Cash & equivalents (year end)$534M$621M$580M
Total debt (year end)$1.3B$2.0B$1.8B
Diluted shares76M76M75M
  • Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
  • Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
  • Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
  • Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
  • Total debt: The current part of long-term debt plus long-term debt, at carrying value.
  • Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.

Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator

Explainers for this page

Plain-English guides to terms this file uses, with real numbers from filings.

About these numbers

    Recent filings

    FormFiledPeriod
    10-QOct 28, 2026Sep 30, 2026
    10-QJul 29, 2026Jun 30, 2026
    10-QApr 29, 2026Mar 31, 2026
    DEF 14AMar 26, 2026May 6, 2026
    10-KFeb 19, 2026Dec 31, 2025

    Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters

    Common questions about IDEX

    How does IDEX make money?

    Fiscal 2025 revenue: $3.5B. By segment in FY2025: Health and Science Technologies (43%), Fluid and Metering Technologies (35%) and Fire and Safety Diversified Products (22%), as shares of total revenue. Total revenue was $3.5B. Source: 10-K for fiscal 2025, filed Feb 19, 2026.

    What was IDEX's revenue in fiscal 2025?

    $3.5B, up 5.8% from fiscal 2024 ($3.3B). The year ended Dec 31, 2025; for fiscal 2023 the figure was $3.3B. Source: 10-K for fiscal 2025, filed Feb 19, 2026.

    Is IDEX profitable?

    Net income was $483M in fiscal 2025 (down 4.3%; fiscal 2024 was $505M). That counts as a GAAP profit. The latest quarter, ended Sep 30, 2026: net income was $144M. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 19, 2026.

    What did IDEX report in its latest quarterly filing?

    For the three months to Sep 30, 2026: revenue $952M (up 8.3% from $879M) and net income $144M (up 12.8% from $128M). Source: 10-Q for the quarter ended Sep 30, 2026, filed Oct 28, 2026.

    How much cash and debt does IDEX have?

    As of Sep 30, 2026: $602M of cash and cash equivalents, $1.8B of total debt. Total debt here is the current part of long-term debt plus long-term debt, at carrying value. Source: 10-Q filed Oct 28, 2026.

    What are the main risks IDEX faces?

    IDEX's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 19, 2026. Risks that are common among companies in the industrial machinery & supplies & components industry include Economic cycles; costs and supply; trade and tariffs; contracts and backlog; regulation and liability. The first: Demand for equipment and services rises and falls with business investment. Source: 10-K, Item 1A Risk Factors.

    Where do these IDEX numbers come from?

    The 10-K filed Feb 19, 2026 (fiscal 2025) and the 10-Q filed Oct 28, 2026 (quarter ended Sep 30, 2026), as published in the SEC's XBRL data. Click any number to open the filing it came from. Methodology explains how fiscal years and missing numbers are handled.

    Tracked funds that report owning IDEX

    From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.

    Disclosures

    Editor holdings in IEX
    The editor holds no position in IDEX (IEX). As of Nov 11, 2026.
    Trading rule
    The editor does not buy or sell IEX from 3 days before to 3 days after this page is published or substantively updated.
    Compensation
    Nobody paid for this page. No affiliate links on this page.
    Sources
    The company's SEC filings, linked next to each number or, for charts, in the source line under them.
    Last updated
    Nov 10, 2026

    General education, the same for every reader. Not a recommendation to buy, sell or hold IEX, and it doesn't consider your situation.

    Compare with peers

    CompanyFiscal yearRevenueRevenue growthNet income
    IDEXIEXFY2025$3.5B+5.8%$483M
    Parker HannifinPHFY2026$21.5B+8.3%$3.6B
    Illinois Tool WorksITWFY2025$16.0B+0.9%$3.1B
    W. W. GraingerGWWFY2025$17.9B+4.5%$1.7B
    Ingersoll RandIRFY2025$7.7B+5.7%$581M

    Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.

    More company files

    New to filings? Learn has plain-English explainers and Tools has calculators. Methodology & Disclosures covers where every number comes from.